GLP-1 medicines · 2026-11
GLP-1 Medicines: Weight & Health
GLP-1 medicines, sleep, and the life beyond a prescription
Read this issue →NEW · CARDIOVASCULAR HEALTH
Lp(a): The Inherited Risk
What runs in families, what clinicians can act on now, and why a new trial changes the treatment conversation.
Read the Lp(a) magazine → · PCSK9 Medicines: Lowering LDL Cholesterol →
THE ARISING / MONTHLY MAGAZINES
The science of better health.
Explore GLP-1 medicines, brain health and dementia, and cancer screening. Read the evidence, its promise, and its limits.
Swipe to explore the current issues →
Brain health & dementia · 2026-11
The Future of Memory
Dementia: the mind, the years, and the care that makes life possible
Read this issue →
Cancer screening · 2026-11
Finding Cancer Earlier
What a blood test can reveal, what it cannot, and why the outcome matters more than the signal.
Read this issue →THE ARISING · BY JOHN GRIFFIN, MD
The science of
a longer life.
The possibilities
of a fuller one.
A physician’s view of longevity, medicine, and the discoveries changing what comes next.
Curiosity. Evidence. A reason to look ahead.
01 / THE NEWSLETTERRead an edition ↗02 / GO DEEPERExplore monthly magazines ↗03 / THE ATLASFollow a connection ↗04 / FIND YOUR INTERESTSearch the collection ↗
FEATURED ARTICLES
Worth a closer look.
2026-11-01 · Light & sleep
The clock changed. Your body follows the light.
A seasonal reading on daylight, sleep timing and the routines around rest.
Read the article →
2026-11-01 · Nutrition & metabolic health
Remission is a beginning. What helps it last?
The RESET diabetes trial, its six-month result, and the next question.
2026-10-31 · Strength & movement
CoQ10: from energy to evidence
What a systematic review can tell us about supplements and physical capacity.
2026-10-30 · Metabolic health
Retatrutide: greater weight loss, more treatment withdrawals
Benefits and tolerability in company-reported trial results. Full peer-reviewed results remain a separate step.
2026-10-29 · Brain health
Exercise and thinking skills in mild cognitive impairment
Cognitive test results, study limitations, and the questions that remain.
2026-10-28 · Metabolic health
GLP-1 medicines and bone density: what eight trials can tell us
A closer look at bone density, weight loss, and the limits of a small evidence base.
48 SUBJECTS · ONE CONNECTED COLLECTION
What matters to you?
From sleep and strength to genomics, AI, robotics, and relationships. Every subject has its own reading page.
Sleep & rhythm
Light, daily rhythms, breathing and brain health.
Explore & read →Strength for the long run
Movement, rehabilitation, muscle, cognition and supplements.
Explore & read →GLP-1 medicines, in context
Metabolic health, bone health, sleep apnea and emerging medicines.
Explore & read →Reading the evidence
How to interpret biomarkers, trial results and unanswered questions.
Explore & read →THE ATLAS · LIFE IN THE LOOP
One question
leads to another.
Explore 36,077 indexed article topics across health, biology, AI, physics, engineering, Earth and space. Follow each entry to its source and connected reading.
Explore the Atlas →Connections invite inquiry. Each study still has to stand on its own evidence.
THE NEWSLETTER ARCHIVE
A growing body of work.
Browse 42 available editions and reader selections, including daily reading and editions for different stages and interests. Each keeps its original date.
Browse newsletter editions →A continuing collectionDaily discoveries and editions for different stages and interests.
Read your wayBrowse by date or interest. Read editions and clearly marked partial selections on the website, with original PDFs where available.
A physician’s curiosity. Sources you can follow. Articles explain what was studied, what was found, and what remains uncertain.
Our editorial standards →